Contents of this document
- Acquisition and new consolidation of U.S.-based Ultradent Products, Inc.
- Acquisition of JSR
- Expansion of monomer production capacity for eyeglass lenses
- New TAFMER® facility and new high-performance PP production facility
- Production facility for next-generation CNT pellicles for EUV lithography
- Creating synergies through the mutual use of technology and sales networks with UPI
- Exchange rate¥159 /US$Year on year against the same period last year+13.0%
- Domestic naphtha price (first half)¥108,350 /KLYear on year against the same period last year+43,450.0%
- Cracker utilization rateJust under 70%
- UPI revenue growth rate (CY25→CY26)10 %
- UPI revenue CAGR, CY23→CY266 %
- UPI CY26 ROSOver 10%
- Volume variance in revenue (consolidated first half)¥212 billion
- Price variance in revenue (consolidated first half)¥1,443 billion
- Life & Healthcare SolutionsRevenue¥1,346 billion (YoY +17.0%)Core operating profit¥127 billion (YoY -2.0%)
- Mobility SolutionsRevenue¥3,004 billion (YoY +16.0%)Core operating profit¥366 billion (YoY +41.0%)
- ICT SolutionsRevenue¥1,592 billion (YoY +16.0%)Core operating profit¥248 billion (YoY +39.0%)
- Growth AreasRevenue¥5,942 billion (YoY +16.0%)Core operating profit¥741 billion (YoY +30.0%)
- Basic & Green MaterialsRevenue¥3,765 billion (YoY +27.0%)Core operating profit¥282 billion
- OtherRevenue¥84 billion (YoY +12.0%)Core operating profit¥-30 billion
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | FY2026 second quarter (interim period) |
| Net Sales | ¥9,791 billion (YoY +20.0%) |
| Operating profit | ¥938 billion (YoY +236.0%) |
| Ordinary income | ¥906 100 million (profit before tax) (YoY +246.0%) |
| Net income | ¥588 100 million (interim profit attributable to owners of the parent) (YoY +650.0%) |
| Results for the three months of the current quarter | Revenue April-June ¥4,600 billion / July-September ¥5,191 billion / Core operating profit April-June ¥501 billion / July-September ¥492 billion |
| Full-year earnings forecast | Revenue ¥20,950 billion / Core operating profit ¥1,500 billion / Non-recurring items ¥-380 billion / Operating profit ¥1,120 billion / Financial income and expenses ¥-110 billion / Pretax profit ¥1,010 billion / Profit for the year attributable to owners of the parent ¥530 billion / Annual Dividend 75 yen per share |
| Segment results | Segment Life & Healthcare Solutions / Revenue ¥1,346 billion (YoY +17.0%) / Core operating profit ¥127 billion (YoY -2.0%), Segment Mobility Solutions / Revenue ¥3,004 billion (YoY +16.0%) / Core operating profit ¥366 billion (YoY +41.0%), Segment ICT Solutions / Revenue ¥1,592 billion (YoY +16.0%) / Core operating profit ¥248 billion (YoY +39.0%), Segment Growth Areas / Revenue ¥5,942 billion (YoY +16.0%) / Core operating profit ¥741 billion (YoY +30.0%), Segment Basic & Green Materials / Revenue ¥3,765 billion (YoY +27.0%) / Core operating profit ¥282 billion, Segment Other / Revenue ¥84 billion (YoY +12.0%) / Core operating profit ¥-30 billion |
| Breakdown of Factors Affecting the Change | First-half core operating profit Volume variance ¥65 billion / Terms of trade ¥492 billion / Fixed costs and other factors ¥-9 billion / Full-year core operating profit forecast Volume variance ¥220 billion / Terms of trade ¥450 billion / Fixed costs and other factors ¥-170 billion |
| Key KPIs | Indicator name Exchange rate / Value ¥159 /US$ / Year on year against the same period last year ¥13 /US$, Indicator name Domestic naphtha price (first half) / Value ¥108,350 /KL / Year on year against the same period last year ¥43,450 /KL, Indicator name Cracker utilization rate / Value Just under 70% / Year on year against the same period last year Not disclosed, Indicator name UPI revenue growth rate (CY25→CY26) / Value 10 % / Year on year against the same period last year Not disclosed, Indicator name UPI revenue CAGR, CY23→CY26 / Value 6 % / Year on year against the same period last year Not disclosed, Indicator name UPI CY26 ROS / Value Over 10% / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | Indicator name Volume variance in revenue (consolidated first half) / Value ¥212 billion, Indicator name Price variance in revenue (consolidated first half) / Value ¥1,443 billion |
| Assumptions Underlying the Business Outlook | Exchange rate ¥157 /US$ / Domestic naphtha price ¥101,700 /KL / Second-half domestic naphtha price ¥95,000 /KL |
| Risk amount incorporated into the outlook | Impact of the situation in the Middle East -80 Approximately ¥100 million |
| Annual Dividend | Annual 75 yen per share / Interim 37.5 yen per share / End of period 37.5 yen per share |
| New initiatives | Acquisition and new consolidation of U.S.-based Ultradent Products, Inc., Acquisition of JSR, Expansion of monomer production capacity for eyeglass lenses, New TAFMER® facility and new high-performance PP production facility, Production facility for next-generation CNT pellicles for EUV lithography, Creating synergies through the mutual use of technology and sales networks with UPI |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Profit growth was driven by higher sales volumes in growth areas, the benefits of structural improvements in each segment, foreign exchange gains from the weaker yen, and one-off inventory valuation gains associated with higher naphtha prices. At the same time, the company was affected by production and sales volume reductions resulting from the situation in the Middle East.